14-day Premium Trial Subscription Try For FreeTry Free
$0.90
-0.0035 (-0.387%)
At Close: May 03, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.86 $1.27 Friday, 3rd May 2024 BLUE stock ended at $0.90. This is 0.387% less than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 6.11% from a day low at $0.89 to a day high of $0.94.
90 days $0.86 $1.92
52 weeks $0.86 $5.53

Historical bluebird bio prices

Date Open High Low Close Volume
Dec 10, 2021 $9.33 $9.47 $8.90 $8.96 1 280 183
Dec 09, 2021 $9.89 $9.96 $9.37 $9.38 1 665 072
Dec 08, 2021 $10.04 $10.06 $9.70 $10.00 1 600 482
Dec 07, 2021 $10.07 $10.35 $9.85 $9.95 1 617 130
Dec 06, 2021 $9.90 $10.19 $9.79 $10.01 1 360 100
Dec 03, 2021 $10.63 $10.65 $9.88 $9.95 1 216 333
Dec 02, 2021 $9.97 $10.68 $9.84 $10.63 1 501 360
Dec 01, 2021 $10.22 $10.77 $10.05 $10.05 1 464 514
Nov 30, 2021 $10.16 $10.46 $9.89 $10.11 1 531 287
Nov 29, 2021 $10.76 $10.90 $10.30 $10.33 1 305 921
Nov 26, 2021 $10.60 $10.89 $10.35 $10.50 1 816 606
Nov 24, 2021 $10.59 $10.92 $10.46 $10.76 4 602 460
Nov 23, 2021 $10.39 $10.75 $10.21 $10.73 1 691 563
Nov 22, 2021 $11.31 $11.36 $10.40 $10.54 2 179 677
Nov 19, 2021 $10.80 $11.05 $10.54 $10.70 1 418 962
Nov 18, 2021 $11.34 $11.34 $10.76 $10.91 1 637 524
Nov 17, 2021 $11.55 $11.60 $11.09 $11.31 1 163 901
Nov 16, 2021 $11.48 $11.65 $11.23 $11.58 1 705 576
Nov 15, 2021 $11.80 $11.81 $11.12 $11.48 1 314 685
Nov 12, 2021 $11.50 $11.76 $11.13 $11.68 1 667 090
Nov 11, 2021 $11.28 $12.12 $11.25 $11.68 2 209 858
Nov 10, 2021 $10.73 $11.74 $10.60 $11.31 4 420 338
Nov 09, 2021 $10.70 $10.88 $10.35 $10.88 3 746 705
Nov 08, 2021 $12.62 $12.62 $10.59 $10.70 8 177 711
Nov 05, 2021 $17.74 $17.85 $12.90 $13.14 6 123 474
Click to get the best stock tips daily for free!

About bluebird bio

bluebird bio bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell disease (SCD); and elivaldogene autotemcel to treat cerebral adrenoleukodystrophy. The company's clini... BLUE Profile

Golden Star

Ticker Date Change Price
CVBF May 01 2.75% $16.75
FTSL May 01 0.282% $46.03
EQC Apr 30 0.694% $18.72
HRB Apr 30 0.635% $47.23
BSCQ Apr 30 0.576% $19.09
BSJP Apr 29 0.306% $22.91
LYG Apr 29 1.56% $2.56
ORA Apr 29 4.68% $64.48
DHT Apr 24 3.10% $11.28
LPLA Apr 19 3.12% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT